Market News AIOpen the app

SMMT stock news · Summit Therapeutics Inc.

Stories about Summit Therapeutics Inc. (SMMT) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SMMT

Follow Summit Therapeutics Inc. (SMMT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SMMT
Free on the App Store and Google Play, or on the web.
  1. Sep 29, 2026, 9:17 AM ET · Market

    AstraZeneca is putting $2 billion into Summit Therapeutics after a lot of guessing about it.

    Good for SMMT

    Summit receives $2 billion from newly issued shares, giving it funding for drug development after warning it might have to cut research. The planned trials still have no reported results.

  2. Sep 29, 2026, 8:23 AM ET · Market

    12 health care stocks are changing a lot before the market opens on Tuesday.

    Neutral

    Summit Therapeutics was listed among pre-market gainers. The article gives no company news explaining the move, so it does not change the view of its business.

  3. Sep 14, 2026, 8:47 AM ET · Market

    Summit Therapeutics says its partner Akeso will share new results from a big trial at a conference.

    Neutral

    Summit filed an 8-K stating Akeso will present updated Phase III HARMONi-2 data, including overall survival; the filing gives no results and does not change how we read Summit today.